Tag Archives: Valeant Pharmaceuticals Intl Inc (VRX)

Valeant Pharmaceuticals Intl Inc VRX

Valeant Pharmaceuticals Intl Inc (VRX), Actavis plc (ACT), Clovis Oncology Inc (CLVS): Top 3 Holdings of Redmile Group LLC

Valeant Pharmaceuticals Intl Inc (VRX), Actavis plc (ACT), Clovis Oncology Inc (CLVS): Top 3 Holdings of Redmile Group LLC

Redmile Group LLC is a fully registered professional investment advisor that works on percentage on assets under management and performance based fees. The firm has its bases in San Francisco, U.S. The SEC 13F filings of Redmile Group LLC for the period ended September 30, 2014, indicated that its top three holdings are Valeant Pharmaceuticals

Actavis plc (ACT)

Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX), Charter Communications, Inc. (CHTR): Top 3 Holdings of Ratan Capital Group

Ratan Capital Group is a hedge fund that invests in equities that show growth and are secure. The firm focuses on ensuring the safety of investor funds and employs proper knowledge and planning in all its investment activities. Ratan Capital Group submitted its SEC 13F filings for the period ended September 30, 2014, showing that

Actavis plc (ACT)

Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX), VASCO Data Security International, Inc. (VDSI): Top 3 Holdings of Private Capital Management

Private Capital Management is a duly registered employee-owned investment advisor founded in 1998. The firm focuses its investments on highly profitable companies. The top three holdings of Private Capital Management, according to its SEC 13F filings for the period ended September 30, 2014, are Actavis plc (NYSE:ACT), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), VASCO Data Security

Vulcan Materials Company VMC

Vulcan Materials Company (VMC), Valeant Pharmaceuticals Intl Inc (VRX), Starwood Hotels & Resorts Worldwide Inc (HOT): Top 3 Holdings of Partner Fund Management, LP

Partner Fund Management, LP, is an employee owned hedge fund providing its services to pooled investment vehicles and manages accounts for corporations. The firm invests globally and has its headquarters in San Francisco, California. The top three holdings of Partner Fund Management, LP, are Vulcan Materials Company (NYSE:VMC), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and Starwood

Valeant Pharmaceuticals Intl Inc VRX

Valeant Pharmaceuticals Intl Inc (VRX), Magellan Midstream Partners, L.P. (MMP), Cinemark Holdings, Inc. (CNK): Top 3 Holdings of Osterweis Capital Management LLC

Osterweis Capital Management LLC is an investment manager founded in 1983 to serve the portfolio management needs of foundations, high net worth individuals, and endowments. The firm has grown to over $10 billion in value of assets under its management. The third quarter SEC 13F filings of Osterweis Capital Management LLC showed that Valeant Pharmaceuticals

Allergan (AGN)

Latest Strategy in Valeant Pharmaceuticals Intl Inc (VRX) -Pershing- Allergan Inc (AGN) Negotiation – Raising Bid Price

What happens when the share price of a particular company jumps by $15? There is an increase in the overall value of the company and this happens to be the latest strategy employed by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Pershing to persuade Allergan Inc (NYSE:AGN) to give its nod to the merger. April, 2014,

Allergan (AGN)

Allergan Inc (AGN) Sets Date to Decide On Possible Valeant Pharmaceuticals Intl Inc (VRX) Take-Over

Having lost a court battle intended to stall the aggressive proceedings of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Allergan Inc (NYSE:AGN) finally released the date for special meeting of shareholders as being December 18th, 2014. This date is a fall-out of decision of legal law-suit that went against Allergan Inc (NYSE:AGN) and in favor of Valeant

Allergan Inc. (AGN)’s Shareholders Request Special Meeting About The Valeant Pharmaceuticals Intl Inc (VRX)

Allergan Inc. (NYSE:AGN) received written requests from its shareholders who are calling for a special meeting in regards to Valeant Pharmaceutical International Inc.’s intent to acquire Allergan.  Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and Pershing Square Capital Management are chasing Allergan Inc. with a $54 billion deal in hand. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) wants Allergan Inc.

Allergan, Inc. (AGN) vs. Valeant Pharmaceuticals Intl Inc (VRX): Losing Ground to Stop Shareholder Meeting

Allergan, Inc. (NYSE:AGN) lost a crucial court bid that could have allowed the company to stop a shareholder meeting planned by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and William Ackman. Ackman joined hands with Valeant in April with a cash-and-stock bid of $54 billion. (You can see entire holdings of William Ackman). Allergan, Inc. (NYSE:AGN) approached

Top